Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply

A. H. Talal; J. Lafleur; R. S. Hoop; P. Pandya; P. Martin; I. M. Jacobson; J. Han; E. J. Korner

doi:10.1111/apt.12424

Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply

A. H. Talal
, J. Lafleur
, R. S. Hoop
, P. Pandya
, P. Martin
, I. M. Jacobson
, J. Han
, E. J. Korner

Medicine

University of Utah
Genentech, Inc
VA Medical Center
University of Miami
Cornell University

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Original language	English
Pages (from-to)	554-555
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	38
Issue number	5
DOIs	https://doi.org/10.1111/apt.12424
State	Published - Sep 2013

Access to Document

10.1111/apt.12424

Cite this

Talal, A. H., Lafleur, J., Hoop, R. S., Pandya, P., Martin, P., Jacobson, I. M., Han, J., & Korner, E. J. (2013). Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply. Alimentary Pharmacology and Therapeutics, 38(5), 554-555. https://doi.org/10.1111/apt.12424

@article{8a1b342501b5480290699b1275721499,

title = "Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply",

author = "Talal, \{A. H.\} and J. Lafleur and Hoop, \{R. S.\} and P. Pandya and P. Martin and Jacobson, \{I. M.\} and J. Han and Korner, \{E. J.\}",

year = "2013",

month = sep,

doi = "10.1111/apt.12424",

language = "English",

volume = "38",

pages = "554--555",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc",

number = "5",

}

Talal, AH, Lafleur, J, Hoop, RS, Pandya, P, Martin, P, Jacobson, IM, Han, J & Korner, EJ 2013, 'Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply', Alimentary Pharmacology and Therapeutics, vol. 38, no. 5, pp. 554-555. https://doi.org/10.1111/apt.12424

TY - JOUR

T1 - Commentary

T2 - Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply

AU - Talal, A. H.

AU - Lafleur, J.

AU - Hoop, R. S.

AU - Pandya, P.

AU - Martin, P.

AU - Jacobson, I. M.

AU - Han, J.

AU - Korner, E. J.

PY - 2013/9

Y1 - 2013/9

UR - https://www.scopus.com/pages/publications/84882332024

U2 - 10.1111/apt.12424

DO - 10.1111/apt.12424

M3 - Comment/debate

AN - SCOPUS:84882332024

SN - 0269-2813

VL - 38

SP - 554

EP - 555

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 5

ER -

Commentary: Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C - Authors' reply

Access to Document

Other files and links

Fingerprint

Cite this